Related Experiment Videos
Depression in children and adolescents
1Indiana University School of Medicine, Indianapolis, 702 Barnhill Drive, Indianapolis, IN 46202, USA.
Neurologic Clinics
|January 28, 2004
Summary
Pediatric depression is often missed due to irritability and perceived moodiness. Treatment involves psychotherapy and selective serotonin reuptake inhibitors (SSRIs) as a primary medication choice.
Area of Science:
- Child and Adolescent Psychiatry
- Pediatric Mental Health
- Neurodevelopmental Disorders
Background:
- Depression is a prevalent mental health issue in children and adolescents.
- Symptoms like irritability may mask depression, leading to underdiagnosis.
- Childhood moodiness is often mistakenly viewed as a normal developmental stage.
Purpose of the Study:
- To highlight the challenges in diagnosing pediatric depression.
- To underscore the association of depression with other disorders.
- To outline current therapeutic approaches for childhood depression.
Main Methods:
- Review of clinical presentations of pediatric depression.
- Analysis of comorbidities in affected youth.
- Summary of established treatment guidelines.
Main Results:
- Irritability is a key symptom that can obscure depressive disorder in children.
- Depression frequently co-occurs with other psychiatric and neurological conditions.
- Psychotherapy and pharmacotherapy, particularly SSRIs, are standard treatments.
Conclusions:
- Early recognition of depression in children and adolescents is crucial.
- Addressing associated conditions is vital for comprehensive care.
- Selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacotherapy.